SCHEMBL15020751

SCHEMBL15020751

Cc1c(OCc2ccccc2)c(=O)ccn1CCN(CCN)CCN

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
ALDH1A1 P00352 2/20 0.64
HPGD P15428 1/20 0.64
NPC1 O15118 1/20 0.59
NPSR1 Q6W5P4 2/20 0.58
LMNA P02545 2/20 0.42
MAPT P10636 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
MAPK14 Q16539 2/20 0.40
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
CYP2D6 P10635 1/20 0.38
MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8122829 0.88 HTT (0.73) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL12944429 0.85 MEN1 (0.70) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL3289112 0.85 HTT (0.70) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL15020752 0.83 HTT (0.41) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL16882316 0.83 SMN1; SMN2 (0.73) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL13003556 0.82 HTT (0.77) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL3358984 0.81 HTT (0.75) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL30669320 0.81 HTT (0.75) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL3357703 0.80 HTT (0.73) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL20382958 0.79 HTT (0.71) HTTSMN1; SMN2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130157375-A1 COMPOUND LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE (GB) 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130157375-A1 COMPOUND TFRC, FTH1, SLC40A1 HTT 1218/4885SMN1; SMN2 2874/4885MEN1 2671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.